Preparing for the General Data Protection Regulation (GDPR)

3 May, 2018 | Posted in:

You may have heard about the EU’s new privacy law General Data Protection Regulation (GDPR). Sarah Gillett, the Neurology Academy’s Managing Director, has been talking to Toby Foster this morning on BBC Radio Sheffield about what the Academy does to comply with upcoming legislation. You can listen to the interview about the GDPR here. (Source: BBC […]

Continue Reading »

Invitation to an evening debate on 9 May

25 April, 2018 | Posted in:

You may be aware of the new ‘Recommendations for an NHS England algorithm to use disease-modifying drugs to treat Multiple Sclerosis’ is currently out for public consultation. The algorithm raises several issues for clinical practice. We are hosting an evening dinner in the ICC where the Association of British Neurologists (ABN) is being held, on […]

Continue Reading »

Fingolimod safety considerations in real world practice – Assessing screening for macular oedema

5 February, 2018 | Posted in:

Dr Paul Gallagher and Dr Sarah-Jane Martin from the Institute of Neurological Sciences in Glasgow undertook their MS Masterclass project to understand if patients in their Centre on Fingolimod were adequately screened for macular oedema. Fingolimod is a first in class sphingosine-1 phosphate (S1P) receptor modulator and was the first oral DMT licensed for use […]

Continue Reading »

HSJ round table Achieving Consistent Care In Neurology

11 January, 2018 | Posted in:

The Neurology Academy has been delighted to participate in the recent HSJ round table Achieving Consistent Care In Neurology held in London before Christmas. Our representing Faculty members Prof Gavin Giovannoni and Ms Sue Thomas joined other national key opinion leaders to explore some of the issues and highlight what needs to change if consistent […]

Continue Reading »